In subgroup patients with SCLC, with a cut-off value of 2.421 ng/ml, TIMP-2 had a sensitivity of 66.7% and a specificity of 57.5%, in predicting the malignant nature of pulmonary mass. The gene discussed is TIMP2; the disease is small cell lung carcinoma.